C3MEDICAL HOPITAL NETWORK

Over the years, thanks to substantial learning experiences and daily contact with thousands of patients who have been welcomed to France, C3Medical has developed strong ties with the elite from within the 3,065 French public and private hospitals, together with their world-class teams.

Here you will find a short introduction to some of them.

 

INSTITUT CURIE

Awarded 6 Nobel Prizes, Institut Curie has been at the forefront of the fight against cancer since 1909.  

C3Medical is proud to manage the international patients of Institut Curie.

Based in Paris on 3 locations, the Institut Curie is a private non-profit foundation and one of the leading medical, biological and biophysical research centers in the world.  

Since its foundation in 1909 - and the first to operate as such -, Institut Curie brings together on the same site both medical and the research teams.

This team co-working organization led to the introduction of major medical innovations such as radio-therapy in the 1920s, being one of the first hospitals in the world to operate a proton-therapy center in 1991, and more recently, the use of artificial intelligence, DNA research and immunotherapy. 

HISTORY

The Institut du Radium, a giant laboratory for Marie Curie, was founded in 1909 by the University of Paris and Institut Pasteur. 

The Institut du Radium had 2 divisions:

  • The Curie laboratory, directed by Marie Curie, dedicated to physics and chemistry research
  • The Pasteur laboratory, directed by Dr. Claudius Regaud, to study the biological and medical effects of radioactivity

After receiving a joint Nobel Prize with her husband Pierre in 1903, Marie Curie won a second Nobel Prize for Chemistry in 1911. During the First World War, Marie Curie used her celebrity to teach nurses about radiology and to raise funds to fit ambulances with radiology equipment. Marie Curie and Dr. Claudius Regaud established the Foundation Curie in 1920, recognized as a public-interest institution. 

The Foundation’s purpose was to fund the Institut du Radium’s activities and contribute to the development of its therapeutic activites. A first hospital opened in 1922, where Dr. Regaud and his team developed the first treatments combining surgery and radiation therapy to care cancer. 

The Curie Foundation became the first cancer hospital and a model for cancer centers throughout the world. 
Curie laboratory continued to play an important role in physics and chemistry research. In 1934, Marie Curie's daughter Irène and her son-in-law Frédéric Joliot-Curie discovered artificial radioactivity. In 1935, this breakthrough was awarded with a Nobel Prize in Chemistry. 

The Institut du Radium and the Fondation Curie merged in 1970 to become Institut Curie, concentrating on 3 missions: research, teaching and treating cancer.

In total, 6 Nobel prizes have been awarded to the Institut Curie research teams:

  • Marie Curie, Physics, 1903
  • Pierre Curie, Physics, 1903
  • Marie Curie. Chemistry, 1911
  • Irène Joliot-Curie, Chemistry, 1935
  • Frédéric Joliot-Curie, Chemistry, 1935
  • Pierre-Gilles de Gennes, Physics, 1991

RESEARCH & TEACHING

Institut Curie now operates several research units in cooperation with national research institutions - such as CNRS (National Scientific Research Center), INSERM (National Heath and Medicine Research Center) -, European and international institutions.

The international staff is 1,100 strong, divided into 86 teams. 

In 2016, Institut Curie researchers have produced 777 publications, conducted 31 European high-tech research projects in different fields:  

  • Genetics and Epigenetics
  • Molecular Biology of the Cell
  • Development and Cancer
  • Physical Chemistry of Cells
  • Immunotherapies of Cancers
  • Bioinformatics and Systems Biology
  • Biology & Chemistry of Radiations
  • Cell Signaling and Cancer 
  • Imaging: from molecules to living organism
  • Tumor Biology-Immunology-Microenvironment
  • Physics-Biology-Chemistry and Cancer

HOSPITAL

Institut Curie hospital is exclusively dedicated to cancer treatment, by radiotherapy, proton-therapy, surgery and chemotherapy, with 365 beds and 86 chemotherapy treatment chairs.

The Institut Curie now runs the Claudius Régaud hospital with its team of 2,100 doctors and medical assistants, and since 1991, a proton therapy center. 

The proton therapy center, located in Orsay, South of Paris, is one of the few and the earliest of such facilities to operate in the world. In terms of activity, it is ranked N°1 for ophthalmologic cancers and N°4 for all other types of cancers.

In the treatment for other types of cancer, Institut Curie Hospital’s core expertise deals with:

  • Pediatric cancers
  • Eye tumors
  • Breast cancers
  • Lung cancers
  • Complex sarcomas surgery

In 2016, the hospital has welcomed 51,486 patients of 79 different nationalities.

NUCLEAR MEDICINE INFRASTRUCTURE

Institut Curie gathers state-of-the-art equipment such as

  • 12 accelerators
  • 10 imaging devices
  • 5 nuclear medicine devices
  • 3 proton therapy units with automatic loaders and robots 

PROTON-THERAPY CENTER

In operation for almost 3 decades (1991), the CPO (Centre de Protonthérapie d’Orsay) has 3 treatment rooms: 

  • One for ophthalmological and intra-cranial treatments, where the patient is seated; 
  • One for intra-cranial treatments, where the patient is reclined or seated; 
  • One for intra-cranial locations and/or other parts of the body, equipped with an isocentric arm for treatments in the reclining position,

In the first two treatment rooms - where the proton beam is fixed and horizontal -, the patient is positioned on a table or chair, depending on the beam. 

In order to be able to choose the placement of the beam in relation to the lesion, the patient is placed on a table or robotized chair for ultra-precise positioning.

The room with the isocentric arm lets the beam move 360°. As the patient reclines on a treatment table, the beam is then positioned with fine precision.

The proton accelerator

The proton accelerator is a circular accelerator, known as a cyclotron. 

The proton source – hydrogen plasma – is located at the center of the acceleration chamber. 

The protons are accelerated using an intense electrical field reaching 230 MeV (million electrovolts) before being channeled through a vacuum to the treatment rooms.

The physical advantage and clinical benefit of protons

The benefit of protons is essentially ballistic. 

The proton is a heavily charged particle, which deposits its energy along its trajectory before stopping suddenly at a certain point and delivering a high energy charge.

Beyond this point, the dose is almost zero. The proton tends to go straight and sideways diffusion is low, so that the dose delivered to the tissues surrounding the tumor is slight. 

It is possible to achieve the optimum dose to the tumor without exceeding the maximum admissible dose to the healthy, sensitive adjacent tissues, helping reduce the risk of deferred side effects occurring several weeks to several years after radiation.

Source: Institut Curie website – 2019_06_14

IMM - INSTITUT MUTUALISTE MONTSOURIS

Located in Paris, built in 1999 following the merger of the Centre Médico-Chirurgical de la porte de Choisy (CMC) and the Hôpital International de l’Université de Paris (HIUP), the Institut Mutualiste Montsouris (IMM) is a multidisciplinary hospital, known for its medical and surgical care of serious and complex diseases, in cancerology, cardiovascular, functional and chronic diseases. The IMM has also a maternity unit and adolescent psychiatric center.

The IMM offers medical, surgical expertise and high-end technologies in a modern, functional structure where particular attention is paid to the comfort and well-being of its patients.

Centre of excellence in research and education, the IMM is on the cutting edge of innovation and is one of the leading medical institution in France.

The IMM is a comprehensive, leading-edge hospital

•    470 beds, spread over 55,000 m2, of which, 
•    340 traditional hospital beds in surgery, medicine and obstetrics
•    21 out-patient hospital beds (11 multi-purpose and 10 oncology)
•    28 ambulatory surgery units
•    13 dialysis stations
•    4 units for assisted procreation
•    68 beds and units for adolescent psychiatry (including 30 day-hospital beds)

Every year, it welcomes over 35,000 patients, provides 160,000 consultations and performs more than 15,000 surgical operations.

 

A dedicated team managed by C3Medical to support foreign patients

The IMM welcomes hundreds of patients from all over the world each year, with
one goal in mind, providing the highest quality of care with latest innovations
and highly experienced and trained medical teams. 

It is therefore highly experienced in the organization and understanding o international patients' needs - patients who are often left to their own devices in a country or city they know little about.

 

The IMM has a state-of-the-art technical platform, open 24 hours a day, composed of:

•    17 operating theaters and one SSPI (post interventional care room)
•    Versatile resuscitation service
•    Outpatient surgery units
•    Pneumological, digestive, urological, ENT and cardiovascular exploration platform comprising: tracheobronchial, digestive and ENT endoscopy platforms
•    Functional respiratory, oesophageal, and cardiovascular centers
•    Digestive, urological, gynecological, ENT, cardiovascular, thoracic, medical, orthopedic and ophthalmic consultations.
•    Interventional bronchoscopy service
•    Medical imaging platform with: standard imaging, interventional imaging, ultrasound and Doppler
•    2 latest-generation 64-band scanners (DISCOVERY CT 750 HD),
•    MRI (1.5 tesla),
•    Radiofrequency and cryotherapy units
•    State-of-the-art medical biology laboratory open to all
•    Anatomopathological laboratory
•    Pharmacy for indoor use including Retrocession and UPC (Centralized Preparation Unit for Chemotherapy)
•    Clinical research structure with 3 Clinical Research Associates.
•    Medically assisted procreation service (PMA)

The IMM also hosts the IMM-R Center. An innovative experimentation and applied research center, European leader in terms of research, technical advancements and training.
 

AP-HP - ASSISTANCE PUBLIQUE ET HOPITAUX DE PARIS

Founded in 1849 following the merger of Parisian medical universities and hospitals, some of them among the oldest in the world, the AP-HP (Assistance Publique et Hôpitaux de Paris) is giant public medical conglomerate of 39 hospitals with over 100,000 employees, financed by an annual budget of over €7 billion.  

It is a center of excellence. According to statistics published regularly, eg. 2018 Webometrics, AP-HP is ranked as N° 1 hospital in Europe in terms of activity and efficiency, 8th in the world, N°1 not counting American hospitals. 

It is also the largest biomedical research center in Europe. 

ORGANIZATION

  • 39 hospitals
    • 4 centers dedicated to serious cardiological pathologies
    • 25 hospitals handling severe emergencies
    • 8 hospitals specialized for children
    • 1 hospital fully dedicated to polytraumatisms (accidents)
  • 700 medical departments
  • 117 medical poles

BUDGET AND HUMAN RESOURCES

  • €7.7 billion out of which 58% for salaries, €409 million for investment and R&D
  • Over 100,000 employees, 1st employer of Paris-Ile de France region
  • 12,298 doctors 
  • 19,456 nurses
  • 52,361 paramedics
  • 14,000 technicians
  • 210 different types of jobs

ACTIVITY 

  • 8.3 million patients
  • 5.2 million scheduled consultations
  • 1.4 million emergency consultations
  • 1.35 million in-patient 
  • 347,031 surgeries out of which 92,386 in out-patient
  • 248,909 psychiatric hospitalizations     
  • 2,502 transplants (40% of French total)
  • 37,948 births over the 13 maternity hospitals
  • 16,240 home-hospitalizations
  • 456,557 scanners
  • 195,583 IRM
  • 55,192 gamma camera examinations

EDUCATION, RESEARCH AND COOPERATION

  • 3 medical universities, 7 associated
  • 9,757 scientific publications
  • 4,462 research programs
  • 4,500 clinical trials
  • 825 active patents
  • 7,400 medical students
  • 450 foreign doctors in exchange programs 
  • 47 partnerships with foreign hospitals and universities

EQUIPMENT

  • 20,428 beds, out of which 2,719 for out-patient activity
  • 50 surgical wards with 293 surgical theaters
  • 43 scanners
  • 34 MRI
  • 3 DaVinci robots
     

NECKER - ENFANTS MALADES

HISTORY

At the beginning of the 18th century, the pastor of the Saint-Sulpice church transformed an old boarding school into a small parish hospital: the Hospital of the Jesus Child. In 1751, it became a Royal Foundation and during the French Revolution it was turned into the National Orphan House.

In 1778, Suzanne Necker, the wife of the Finance Minister of Louis XVI, created a hospital located next door, in Sevres street, to be devoted to medicine and surgery for adults. She wanted it to be an exemplary hospital where each patient would have an individual bed. It was in this hospital that René Laennec invented the stethoscope in 1816.

In 1802, the General Hospital Council decided to group together all the orphans into one children’s home, called the Found Children, in the Saint-Antoine suburbs. The former Orphan House was then tranformed into a place of care for all the sick children under 15 years of age, who up to then had been hospitalized in the adult hospitals Hotel Dieu, La Charité, Necker, Cochin and Beaujon. 

This 250 bed hospital was renamed Hôpital des Enfants Malades (Hospital of the Sick Children). It was the first pediatric hospital created in the world.


TODAY

Necker-Enfants Malades hospital is the beneficiary to this dual legacy: beside its services devoted to children's medicine and surgery, it has an adult department of over 200 beds. 

Taking advantage of its unique origins, its medical teams have developed a world class medical service, supported by an exceptional synergy between technical expertise, research units and the clinical units.

As a major refferal center for rare diseases and for complex pathologies, the hospital Necker-Enfants Malades provides services well beyond Paris and its region: more than 20% of the patients come from other provinces in France or from abroad.
 

FACTS AND FIGURES

•    Staff

– 700 Medical personnel  /  3,200 Paramedical personnel
– 600 beds

•    9 Departments

– Specialized Pediatrics
– Pediatric Surgery
– Obstetrics and Pediatric Cardiology
– Intensive care, Emergencies, Anesthesiology
– Hematology, Immunology, Infectiology
– Uro-Nephrology, Ophtalmology
– Imaging
– Laboratory Medicine and Pharmacy
– Clinical Research, Informatics and Public Health

•    Care (per year)

– 62,000 Hospitalizations  
– 74,000 Emergencies
– 2,400 Births
– 310,000 Consultations
– 240 Organ transplants 
– 100,000 Image screening
– 140,000,000 Laboratory analysis
 

QUINZE-VINGTS

The Hospice of Quinze-Vingts was founded in 1260, by King Saint-Louis to accommodate the blind and deprived Parisians. It is the oldest, still active specialized eye hospital in the world.

The large number of crusaders who lost their sight during the Crusades certainly played a role in the hospital's establishment. The name "Quinze-Vingts" (15 times 20) comes from the old twenty-count system, meaning the hospital with 300 beds. 

Today, the Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts (CHNO) persues the missions of an university hospital: care, teaching, research and prevention. 

Entirely focused on a single discipline - ophthalmology -, the CHNO has become over time, a pole of reference in the treatment of pathologies of the vision. It is recognized worldwide and has contributed to the education of several generations of French and foreign ophthalmologists.

The new buildings house 3 organizations:

  • the National Hospital of Ophthalmology (CHNO), 
  • the residence Saint-Louis, a structure for the care of the blind and visually impaired, 
  • the Institut de la Vision, largest European research center for ocular diseases. 

Created in 2008 by Inserm (French Institute of Medical Research) and the Pierre and Marie Curie University, this is the

It operates in a multidisciplinary structure, in which researchers share cutting-edge platforms and pool their resources with other industries based on the site, to discover and test the treatments and technological innovations of tomorrow.

 

STATISTICS

STAFF 

  • 125 doctors
  • 656 medical staff
  • 280 in-house scientists & researchers   

MEDICAL ACTIVITY

  • 309,000 consultations and auxiliary functions
  • 60,242 emergency center visits
  • 31,581 in and out-patients
  • 21,150 surgical acts
  • 10,685 cataract surgeries
  • 3,416 retinal surgeries
  • 1,702 glaucoma surgeries
  • 1,497 refractive surgeries
  • 521 corneal transplants

 

ACADEMIC & RESEARCH ACTIVITY

  • 118 clinical experiments
  • 115 publications 
  • 91 industrial translations
  • 27 French & European academic research programs

 

SOME INSERM CONTRIBUTIONS ON THE QUINZE-VINGTS -TREATMENTS FOR INCURABLE EYE DISEASES 

Since 2001, José-Alain Sahel's hospital career and research activities have been closely linked to the Quinze-Vingts when he joined CHNO as head of the ophthalmology department. Co-founder of the European Institute of Vision, since 2005 he has been coordinator of the INSERM / AP-HP clinical investigation center and, since 2006, director of the national reference center for rare diseases " Hereditary retinal dystrophies ". 

José-Alain Sahel has focused his research activities on incurable retinal diseases. He has, among other things, developed innovative therapies for the protection of retinal photoreceptors and identified proteins reponsible for key mechanisms in maintaining central vision. 

The clinical research carried out in Quinze-Vingts is closely linked to the scientific work carried out by the 280 or so researchers from Inserm, Pierre and Marie Curie University and the CNRS who work today in the institute. 

Various approaches are developed: 

•    Biology of the development of the visual system; 
•    Understanding and evaluation of the processing of visual information; 
•    Decoding of genetic mechanisms involved in ophthalmological diseases;
•    Design and evaluation of innovative treatments


INSTITUT DE LA VISION – EUROPEAN MEDICEN CLUSTER

The history continues to make this hospital a precursor in ophthalmology with the creation of the Institut de la Vision (Institute of Vision), which opened its doors in March 2008 on the site of the CHNO, 17, rue Moreau in Paris. It has been labelled as a structuring project of the global world-class Medicine competitiveness cluster. 

The Institut de la Vision is an international research center entirely dedicated to researching vision diseases.

The innovative organization of the Institut de la Vision - which brings together researchers, doctors and industry with the patients of the National Hospital of Ophthalmology (CHNO) of Quinze-Vingts in Paris - , allows to discover, test and develop new therapeutic solutions or technologies to prevent eye diseases or limit their effects. 

Designed as a place of gathering and exchange, it allows the sharing of ideas, the emergence of new questions and the acceleration of the transfer of research results for the care of patients.

The campus includes, in addition to the Research Center Vision Institute, Clinical Investigation Center CHNO Quinze-Vingts, the Center for Rare Diseases of the Retina Incubator / Nursery See & Hear, which hosts a dozen dynamic start-ups.

All activities and projects of the Vision Institute are coordinated by the Voir & Entendre Foundation, in conjunction with its three umbrella organizations: Sorbonne University, Inserm and CNRS.

Research

The Institute of Vision is home to about twenty academic teams (Sorbonne University - Inserm - CNRS) whose work focuses on diseases of vision and ways to treat them: AMD (Macular Degeneration Linked to Age ), glaucoma, retinopathies pigmented and diabetic, artificial retina, optogenetics, cellular and genetic therapies, retinal imaging, high throughput screening, etc. 

Major collaboration has developed with teams from the Paris Observatory, the Institut Pasteur, the Intercommunal Hospital Center of Créteil, the Langevin Institute and the European Institute of Theoretical Neurosciences.

Several industrialists have also moved to the Vision Institute to develop their projects in an ecosystem dedicated to the vision: discovery of new drugs, imaging, surgery, new technologies, etc.

Researchers and industrialists benefit from the unique facilities of the Vision Institute - some fifteen state-of-the-art technological platforms for eye analysis, exploration and imaging - as well as the functional evaluation platform of the Center of Clinical Investigation of CHNO of Quinze-Vingts.

Caring for patients

Researchers from the Institut de la Vision work on a daily basis with doctors from the CHNO Clinical Investigation Center in Quinze-Vingts.

This center runs more than 60 clinical studies on visual pathologies and their treatments. Current studies include age-related macular degeneration (AMD), retinopathy pigmentosa and diabetic retinal vein occlusion, artificial retina, glaucoma, and high-resolution retinal imaging.

Doctors and researchers also work closely with partner hospitals, including the A. de Rothschild Ophthalmological Foundation, AP-HP (Lariboisière and Pitié-Salpêtrière Hospitals) and the Intercommunal Hospital Center in Paris Créteil.

Statistics

  • 18 teams divided into 5 departments dedicated to academic research in
    • Biology
    • Genetics
    • Imaging tools
    • Visual Information
    • Therapeutics
    • Photonics
  • 280 researchers
  • 20 doctors
  • 12 leading-edge technological platforms
  • 50 ongoing clinical studies
  • 8 international partnering companies

 

Source: Quinze-Vingts hospital website - June 2019

NEURO SAINTE ANNE

Built in 1867, the Sainte-Anne Hospital Center has undergone many changes to become a reference center in Psychiatry and Neuroscience 

Its fields of excellence are the following:

  • Neurology
  • Neuro-vascular surgery
  • Neuro-oncology
  • Complex neuro-anesthesia and resuscitation
  • Electro-convulsivotherapy
  • Pain evaluation and treatment
  • Memory and language deficiency treatment
  • Physical medicine and neuro-orientated rehabilitation

The Neurology Department of the Sainte-Anne Hospital Center is composed of 2 units: 

  • Neurovascular Unit 
  • General Neurology Unit 

NEURO-VASCULAR UNIT (UNV) 

24-hour management of stroke patients: cerebral infarction, transient ischemic attacks, cerebral hemorrhage and meningitis. 

The UNV of Sainte Anne is one of the 4 neuro-vascular recourse units in the Île-de-France region. It has 36 beds including 10 intensive care and benefits from a unique technical platform providing 24-hour access to neuro-radiological imaging services (MRI 1.5T and 3T), interventional neuroradiology (NRI), neurosurgery and neuro-resuscitation. 

More than 1000 cardiovascular cases per year are sent directly by emergency services, partner hospitals or city doctors. 

GENERAL NEUROLOGY UNIT 

Management of patients with Parkinson's disease, tremor, cervical dystonia, writer's cramp, etc. Epilepsy including initial assessment of a first seizure, Multiple Sclerosis and related diseases, Migraine and other headaches, Peripheral nerve diseases, Cerebrovascular Disorders Out of Emergency and Post-Stroke Assessment

NEURO-ONCOLOGY

Neuro-oncology is a very broad clinical and scientific discipline that concerns the diagnostic and therapeutic management of

  • Primary tumors of the central nervous system (glioma, lymphoma, meningioma ...),
  • Neurological complications of tumoral cancers (metastases of the neuroaxis and its envelopes) or not (neurological side effects of anti-neoplastic treatments, paraneoplastic syndromes ...)
  • Neuro-oncogenetic pathologies.

The neurosurgical neuro-oncology functional unit is a central operating element of the neuro Sainte-Anne hospital-university hub for the diagnosis, treatment and follow-up of all tumors of the brain, meninges and nerves.

This is made possible by a multi-disciplinary approach in connection with imaging services, neuropathology, neurology, anesthesia-resuscitation, pain, rehabilitation, psychiatry, and neurophysiology.

The unit is equipped with a state-of-the-art technical platform. Teams work closely together in Multidisciplinary Collaborative Meetings (RCP).

An example of this interaction is the ability to manage brain tumors located in high-risk areas and deemed inoperable by some teams. In particular, the expertise of concious surgery which allows to map the brain functions during the intervention so as to remove the lesions with a maximum of security.

Neuro-oncology represents a major challenge for Neuroscience research within the Pole and Neuro Sainte-Anne's neuro-oncology department is one of the best neurosurgery services in France.

NEUROSURGICAL ANESTHESIA-RESUSCITATION SERVICE

The Anesthesia-Neurosurgical Resuscitation Department is organized into four activity centers: Anesthesia, Neurosurgical Resuscitation, Electroconvulsive Therapy Unit (ECT), Center for Assessment and Treatment of Pain (CETD)

The anesthesiologist doctor provides perioperative management (anesthesia consultation, anesthetic procedures, post-interventional monitoring) of any patient for whom an operative indication is given, whether in the context of a programmed surgery, or an indication of surgical urgency. This anesthetic activity is carried out for the benefit of patients:

  • Suffering from neurosurgical pathology, oncology surgery, epilepsy surgery or vascular surgery,
  • With a pathology of the spine,
  • Requiring diagnostic or therapeutic management of vascular malformations by the interventional neurovascular radiology team,
  • In need of dental care or surgery of the face of patients justifying a treatment of seismotherapy

Neurosurgical resuscitation
This 10-bed unit provides continuity of care for patients managed by the surgical team or the interventional radiology team.

Electroconvulsive therapy unit
Electroconvulsive therapy (ECT) is a psychiatric treatment that consists in causing a generalized comitian crisis by means of an electric current in transcranial application.

The care of the patients by the anesthetist-intensive care physician begins as soon as the psychiatrist gives the indication with the anesthesia consultation.

This procedure is performed under short-term general anesthesia, in specific rooms that include a post-intervention monitoring room.

Center for Assessment and Treatment of Pain (CETD)
Attached to the Department of Anesthesia Neurosurgical Resuscitation, the CETD ensures:

  • Consultations (assessment, management of pain)
  • Acupuncture treatments
  • Psychological care
  • Functional rehabilitation (rehabilitation plateau, balneotherapy)
  • Emergency room
  • The service assures the care of patients admitted as part of the permanence of the local health care and the permanence of recourse (former grand guard)

 PHYSICAL MEDICINE AND NEUROLOGICAL ORIENTATION REHABILITATION (MPR)

The management of patients in the MPR service is provided by a multidisciplinary team composed of a medical practitioner MPR, nurses, caregivers, physiotherapists, occupational therapists, speech therapists, social worker, and psychologist and aims to reduce and prevent the functional, physical, psychological and social consequences of neurological deficiencies.

The MPR service has 2 units:

  • In-patient hospitalization unit
  • Out-patient hospitalization unit

In-patient hospitalization unit
Unit welcoming patients with neurological (motor, sensory, neuropsychological) sequelae neurological lesions.

Out-patient hospitalization unit
Reception of the patient in day hospitalization is proposed during a medical consultation specialized in physical medicine and rehabilitation.

Following admission consultation in MPR Day Hospital, the rehabilitation goals are set with the doctor. A weekly schedule of the proposed sessions is given to the patient with the date of the beginning and end of his / her care.

Exams performed

  • Assessment of deficiencies and sensitivo-motor disabilities in the acute phase or at a distance from a neurological condition,
  • Assessment of impairments and cognitive impairments in the acute or distant phase of a neurological condition,
  • Evaluation and treatment of spasticity:
  • Peripheral neuro-motor block
  • Botulinum toxin injection
  • Functional setting to assess patients' autonomy in activities of daily living
  • Effort rehabilitation after neurological injury
  • Disability and family specific consultations


NEUROLOGY UNIT OF MEMORY AND LANGUAGE

This unit is for patients with memory, language or cognitive impairment.

The goal is to make an accurate diagnosis and to offer multidisciplinary care adapted to the disease. Close collaboration is ensured with the assessment center psychic disorders and aging of Dr. Thierry Gallarda.
 

NEUROPHYSIOLOGY

Functional Explorations - Electroencephalography (EEG) - Electromyography (EMG) - Evoked Potentials (EP)
 

Source: website Neuro Ste Anne - June 2019

INSTITUT CURIE

Awarded 6 Nobel Prizes, Institut Curie has been at the forefront of the fight against cancer since 1909.  

C3Medical is proud to manage the international patients of Institut Curie.

Based in Paris on 3 locations, the Institut Curie is a private non-profit foundation and one of the leading medical, biological and biophysical research centers in the world.  

Since its foundation in 1909 - and the first to operate as such -, Institut Curie brings together on the same site both medical and the research teams.

This team co-working organization led to the introduction of major medical innovations such as radio-therapy in the 1920s, being one of the first hospitals in the world to operate a proton-therapy center in 1991, and more recently, the use of artificial intelligence, DNA research and immunotherapy. 

HISTORY

The Institut du Radium, a giant laboratory for Marie Curie, was founded in 1909 by the University of Paris and Institut Pasteur. 

The Institut du Radium had 2 divisions:

  • The Curie laboratory, directed by Marie Curie, dedicated to physics and chemistry research
  • The Pasteur laboratory, directed by Dr. Claudius Regaud, to study the biological and medical effects of radioactivity

After receiving a joint Nobel Prize with her husband Pierre in 1903, Marie Curie won a second Nobel Prize for Chemistry in 1911. During the First World War, Marie Curie used her celebrity to teach nurses about radiology and to raise funds to fit ambulances with radiology equipment. Marie Curie and Dr. Claudius Regaud established the Foundation Curie in 1920, recognized as a public-interest institution. 

The Foundation’s purpose was to fund the Institut du Radium’s activities and contribute to the development of its therapeutic activites. A first hospital opened in 1922, where Dr. Regaud and his team developed the first treatments combining surgery and radiation therapy to care cancer. 

The Curie Foundation became the first cancer hospital and a model for cancer centers throughout the world. 
Curie laboratory continued to play an important role in physics and chemistry research. In 1934, Marie Curie's daughter Irène and her son-in-law Frédéric Joliot-Curie discovered artificial radioactivity. In 1935, this breakthrough was awarded with a Nobel Prize in Chemistry. 

The Institut du Radium and the Fondation Curie merged in 1970 to become Institut Curie, concentrating on 3 missions: research, teaching and treating cancer.

In total, 6 Nobel prizes have been awarded to the Institut Curie research teams:

  • Marie Curie, Physics, 1903
  • Pierre Curie, Physics, 1903
  • Marie Curie. Chemistry, 1911
  • Irène Joliot-Curie, Chemistry, 1935
  • Frédéric Joliot-Curie, Chemistry, 1935
  • Pierre-Gilles de Gennes, Physics, 1991

RESEARCH & TEACHING

Institut Curie now operates several research units in cooperation with national research institutions - such as CNRS (National Scientific Research Center), INSERM (National Heath and Medicine Research Center) -, European and international institutions.

The international staff is 1,100 strong, divided into 86 teams. 

In 2016, Institut Curie researchers have produced 777 publications, conducted 31 European high-tech research projects in different fields:  

  • Genetics and Epigenetics
  • Molecular Biology of the Cell
  • Development and Cancer
  • Physical Chemistry of Cells
  • Immunotherapies of Cancers
  • Bioinformatics and Systems Biology
  • Biology & Chemistry of Radiations
  • Cell Signaling and Cancer 
  • Imaging: from molecules to living organism
  • Tumor Biology-Immunology-Microenvironment
  • Physics-Biology-Chemistry and Cancer

HOSPITAL

Institut Curie hospital is exclusively dedicated to cancer treatment, by radiotherapy, proton-therapy, surgery and chemotherapy, with 365 beds and 86 chemotherapy treatment chairs.

The Institut Curie now runs the Claudius Régaud hospital with its team of 2,100 doctors and medical assistants, and since 1991, a proton therapy center. 

The proton therapy center, located in Orsay, South of Paris, is one of the few and the earliest of such facilities to operate in the world. In terms of activity, it is ranked N°1 for ophthalmologic cancers and N°4 for all other types of cancers.

In the treatment for other types of cancer, Institut Curie Hospital’s core expertise deals with:

  • Pediatric cancers
  • Eye tumors
  • Breast cancers
  • Lung cancers
  • Complex sarcomas surgery

In 2016, the hospital has welcomed 51,486 patients of 79 different nationalities.

NUCLEAR MEDICINE INFRASTRUCTURE

Institut Curie gathers state-of-the-art equipment such as

  • 12 accelerators
  • 10 imaging devices
  • 5 nuclear medicine devices
  • 3 proton therapy units with automatic loaders and robots 

PROTON-THERAPY CENTER

In operation for almost 3 decades (1991), the CPO (Centre de Protonthérapie d’Orsay) has 3 treatment rooms: 

  • One for ophthalmological and intra-cranial treatments, where the patient is seated; 
  • One for intra-cranial treatments, where the patient is reclined or seated; 
  • One for intra-cranial locations and/or other parts of the body, equipped with an isocentric arm for treatments in the reclining position,

In the first two treatment rooms - where the proton beam is fixed and horizontal -, the patient is positioned on a table or chair, depending on the beam. 

In order to be able to choose the placement of the beam in relation to the lesion, the patient is placed on a table or robotized chair for ultra-precise positioning.

The room with the isocentric arm lets the beam move 360°. As the patient reclines on a treatment table, the beam is then positioned with fine precision.

The proton accelerator

The proton accelerator is a circular accelerator, known as a cyclotron. 

The proton source – hydrogen plasma – is located at the center of the acceleration chamber. 

The protons are accelerated using an intense electrical field reaching 230 MeV (million electrovolts) before being channeled through a vacuum to the treatment rooms.

The physical advantage and clinical benefit of protons

The benefit of protons is essentially ballistic. 

The proton is a heavily charged particle, which deposits its energy along its trajectory before stopping suddenly at a certain point and delivering a high energy charge.

Beyond this point, the dose is almost zero. The proton tends to go straight and sideways diffusion is low, so that the dose delivered to the tissues surrounding the tumor is slight. 

It is possible to achieve the optimum dose to the tumor without exceeding the maximum admissible dose to the healthy, sensitive adjacent tissues, helping reduce the risk of deferred side effects occurring several weeks to several years after radiation.

Source: Institut Curie website – 2019_06_14

IMM - INSTITUT MUTUALISTE MONTSOURIS

Located in Paris, built in 1999 following the merger of the Centre Médico-Chirurgical de la porte de Choisy (CMC) and the Hôpital International de l’Université de Paris (HIUP), the Institut Mutualiste Montsouris (IMM) is a multidisciplinary hospital, known for its medical and surgical care of serious and complex diseases, in cancerology, cardiovascular, functional and chronic diseases. The IMM has also a maternity unit and adolescent psychiatric center.

The IMM offers medical, surgical expertise and high-end technologies in a modern, functional structure where particular attention is paid to the comfort and well-being of its patients.

Centre of excellence in research and education, the IMM is on the cutting edge of innovation and is one of the leading medical institution in France.

The IMM is a comprehensive, leading-edge hospital: 

•    470 beds, spread over 55,000 m2, of which, 
•    340 traditional hospital beds in surgery, medicine and obstetrics
•    21 out-patient hospital beds (11 multi-purpose and 10 oncology)
•    28 ambulatory surgery units
•    13 dialysis stations
•    4 units for assisted procreation
•    68 beds and units for adolescent psychiatry (including 30 day-hospital beds)

Every year, it welcomes over 35,000 patients, provides 160,000 consultations and performs more than 15,000 surgical operations.

 

A dedicated team managed by C3Medical to support foreign patients

The IMM welcomes hundreds of patients from all over the world each year, with
one goal in mind, providing the highest quality of care with latest innovations
and highly experienced and trained medical teams. 

It is therefore highly experienced in the organization and understanding o international patients' needs - patients who are often left to their own devices in a country or city they know little about.

 

The IMM has a state-of-the-art technical platform, open 24 hours a day, composed of:

•    17 operating theaters and one SSPI (post interventional care room)
•    Versatile resuscitation service
•    Outpatient surgery units
•    Pneumological, digestive, urological, ENT and cardiovascular exploration platform comprising: tracheobronchial, digestive and ENT endoscopy platforms
•    Functional respiratory, oesophageal, and cardiovascular centers
•    Digestive, urological, gynecological, ENT, cardiovascular, thoracic, medical, orthopedic and ophthalmic consultations.
•    Interventional bronchoscopy service
•    Medical imaging platform with: standard imaging, interventional imaging, ultrasound and Doppler
•    2 latest-generation 64-band scanners (DISCOVERY CT 750 HD),
•    MRI (1.5 tesla),
•    Radiofrequency and cryotherapy units
•    State-of-the-art medical biology laboratory open to all
•    Anatomopathological laboratory
•    Pharmacy for indoor use including Retrocession and UPC (Centralized Preparation Unit for Chemotherapy)
•    Clinical research structure with 3 Clinical Research Associates.
•    Medically assisted procreation service (PMA)

The IMM also hosts the IMM-R Center. An innovative experimentation and applied research center, European leader in terms of research, technical advancements and training.

AP-HP - ASSISTANCE PUBLIQUE ET HOPITAUX DE PARIS

Founded in 1849 following the merger of Parisian medical universities and hospitals, some of them among the oldest in the world, the AP-HP (Assistance Publique et Hôpitaux de Paris) is giant public medical conglomerate of 39 hospitals with over 100,000 employees, financed by an annual budget of over €7 billion.  

It is a center of excellence. According to statistics published regularly, eg. 2018 Webometrics, AP-HP is ranked as N° 1 hospital in Europe in terms of activity and efficiency, 8th in the world, N°1 not counting American hospitals. 

It is also the largest biomedical research center in Europe. 

ORGANIZATION

  • 39 hospitals
    • 4 centers dedicated to serious cardiological pathologies
    • 25 hospitals handling severe emergencies
    • 8 hospitals specialized for children
    • 1 hospital fully dedicated to polytraumatisms (accidents)
  • 700 medical departments
  • 117 medical poles

BUDGET AND HUMAN RESOURCES

  • €7.7 billion out of which 58% for salaries, €409 million for investment and R&D
  • Over 100,000 employees, 1st employer of Paris-Ile de France region
  • 12,298 doctors 
  • 19,456 nurses
  • 52,361 paramedics
  • 14,000 technicians
  • 210 different types of jobs

ACTIVITY 

  • 8.3 million patients
  • 5.2 million scheduled consultations
  • 1.4 million emergency consultations
  • 1.35 million in-patient 
  • 347,031 surgeries out of which 92,386 in out-patient
  • 248,909 psychiatric hospitalizations     
  • 2,502 transplants (40% of French total)
  • 37,948 births over the 13 maternity hospitals
  • 16,240 home-hospitalizations
  • 456,557 scanners
  • 195,583 IRM
  • 55,192 gamma camera examinations

EDUCATION, RESEARCH AND COOPERATION

  • 3 medical universities, 7 associated
  • 9,757 scientific publications
  • 4,462 research programs
  • 4,500 clinical trials
  • 825 active patents
  • 7,400 medical students
  • 450 foreign doctors in exchange programs 
  • 47 partnerships with foreign hospitals and universities

EQUIPMENT

  • 20,428 beds, out of which 2,719 for out-patient activity
  • 50 surgical wards with 293 surgical theaters
  • 43 scanners
  • 34 MRI
  • 3 DaVinci robots
     

 

NECKER - ENFANTS MALADES

HISTORY

At the beginning of the 18th century, the pastor of the Saint-Sulpice church transformed an old boarding school into a small parish hospital: the Hospital of the Jesus Child. In 1751, it became a Royal Foundation and during the French Revolution it was turned into the National Orphan House.

In 1778, Suzanne Necker, the wife of the Finance Minister of Louis XVI, created a hospital located next door, in Sevres street, to be devoted to medicine and surgery for adults. She wanted it to be an exemplary hospital where each patient would have an individual bed. It was in this hospital that René Laennec invented the stethoscope in 1816.

In 1802, the General Hospital Council decided to group together all the orphans into one children’s home, called the Found Children, in the Saint-Antoine suburbs. The former Orphan House was then tranformed into a place of care for all the sick children under 15 years of age, who up to then had been hospitalized in the adult hospitals Hotel Dieu, La Charité, Necker, Cochin and Beaujon. 

This 250 bed hospital was renamed Hôpital des Enfants Malades (Hospital of the Sick Children). It was the first pediatric hospital created in the world.


TODAY

Necker-Enfants Malades hospital is the beneficiary to this dual legacy: beside its services devoted to children's medicine and surgery, it has an adult department of over 200 beds. 

Taking advantage of its unique origins, its medical teams have developed a world class medical service, supported by an exceptional synergy between technical expertise, research units and the clinical units.

As a major refferal center for rare diseases and for complex pathologies, the hospital Necker-Enfants Malades provides services well beyond Paris and its region: more than 20% of the patients come from other provinces in France or from abroad.
 

FACTS AND FIGURES

•    Staff

– 700 Medical personnel  /  3,200 Paramedical personnel
– 600 beds

•    9 Departments

– Specialized Pediatrics
– Pediatric Surgery
– Obstetrics and Pediatric Cardiology
– Intensive care, Emergencies, Anesthesiology
– Hematology, Immunology, Infectiology
– Uro-Nephrology, Ophtalmology
– Imaging
– Laboratory Medicine and Pharmacy
– Clinical Research, Informatics and Public Health

•    Care (per year)

– 62,000 Hospitalizations  
– 74,000 Emergencies
– 2,400 Births
– 310,000 Consultations
– 240 Organ transplants 
– 100,000 Image screening
– 140,000,000 Laboratory analysis

QUINZE-VINGTS

The Hospice of Quinze-Vingts was founded in 1260, by King Saint-Louis to accommodate the blind and deprived Parisians. It is the oldest, still active specialized eye hospital in the world.

The large number of crusaders who lost their sight during the Crusades certainly played a role in the hospital's establishment. The name "Quinze-Vingts" (15 times 20) comes from the old twenty-count system, meaning the hospital with 300 beds. 

Today, the Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts (CHNO) persues the missions of an university hospital: care, teaching, research and prevention. 

Entirely focused on a single discipline - ophthalmology -, the CHNO has become over time, a pole of reference in the treatment of pathologies of the vision. It is recognized worldwide and has contributed to the education of several generations of French and foreign ophthalmologists.

The new buildings house 3 organizations:

  • the National Hospital of Ophthalmology (CHNO), 
  • the residence Saint-Louis, a structure for the care of the blind and visually impaired, 
  • the Institut de la Vision, largest European research center for ocular diseases. 

Created in 2008 by Inserm (French Institute of Medical Research) and the Pierre and Marie Curie University, this is the

It operates in a multidisciplinary structure, in which researchers share cutting-edge platforms and pool their resources with other industries based on the site, to discover and test the treatments and technological innovations of tomorrow.

 

STATISTICS

STAFF 

  • 125 doctors
  • 656 medical staff
  • 280 in-house scientists & researchers   

MEDICAL ACTIVITY

  • 309,000 consultations and auxiliary functions
  • 60,242 emergency center visits
  • 31,581 in and out-patients
  • 21,150 surgical acts
  • 10,685 cataract surgeries
  • 3,416 retinal surgeries
  • 1,702 glaucoma surgeries
  • 1,497 refractive surgeries
  • 521 corneal transplants

 

ACADEMIC & RESEARCH ACTIVITY

  • 118 clinical experiments
  • 115 publications 
  • 91 industrial translations
  • 27 French & European academic research programs

 

SOME INSERM CONTRIBUTIONS ON THE QUINZE-VINGTS -TREATMENTS FOR INCURABLE EYE DISEASES 

Since 2001, José-Alain Sahel's hospital career and research activities have been closely linked to the Quinze-Vingts when he joined CHNO as head of the ophthalmology department. Co-founder of the European Institute of Vision, since 2005 he has been coordinator of the INSERM / AP-HP clinical investigation center and, since 2006, director of the national reference center for rare diseases " Hereditary retinal dystrophies ". 

José-Alain Sahel has focused his research activities on incurable retinal diseases. He has, among other things, developed innovative therapies for the protection of retinal photoreceptors and identified proteins reponsible for key mechanisms in maintaining central vision. 

The clinical research carried out in Quinze-Vingts is closely linked to the scientific work carried out by the 280 or so researchers from Inserm, Pierre and Marie Curie University and the CNRS who work today in the institute. 

Various approaches are developed: 

•    Biology of the development of the visual system; 
•    Understanding and evaluation of the processing of visual information; 
•    Decoding of genetic mechanisms involved in ophthalmological diseases;
•    Design and evaluation of innovative treatments


INSTITUT DE LA VISION – EUROPEAN MEDICEN CLUSTER

The history continues to make this hospital a precursor in ophthalmology with the creation of the Institut de la Vision (Institute of Vision), which opened its doors in March 2008 on the site of the CHNO, 17, rue Moreau in Paris. It has been labelled as a structuring project of the global world-class Medicine competitiveness cluster. 

The Institut de la Vision is an international research center entirely dedicated to researching vision diseases.

The innovative organization of the Institut de la Vision - which brings together researchers, doctors and industry with the patients of the National Hospital of Ophthalmology (CHNO) of Quinze-Vingts in Paris - , allows to discover, test and develop new therapeutic solutions or technologies to prevent eye diseases or limit their effects. 

Designed as a place of gathering and exchange, it allows the sharing of ideas, the emergence of new questions and the acceleration of the transfer of research results for the care of patients.

The campus includes, in addition to the Research Center Vision Institute, Clinical Investigation Center CHNO Quinze-Vingts, the Center for Rare Diseases of the Retina Incubator / Nursery See & Hear, which hosts a dozen dynamic start-ups.

All activities and projects of the Vision Institute are coordinated by the Voir & Entendre Foundation, in conjunction with its three umbrella organizations: Sorbonne University, Inserm and CNRS.

Research

The Institute of Vision is home to about twenty academic teams (Sorbonne University - Inserm - CNRS) whose work focuses on diseases of vision and ways to treat them: AMD (Macular Degeneration Linked to Age ), glaucoma, retinopathies pigmented and diabetic, artificial retina, optogenetics, cellular and genetic therapies, retinal imaging, high throughput screening, etc. 

Major collaboration has developed with teams from the Paris Observatory, the Institut Pasteur, the Intercommunal Hospital Center of Créteil, the Langevin Institute and the European Institute of Theoretical Neurosciences.

Several industrialists have also moved to the Vision Institute to develop their projects in an ecosystem dedicated to the vision: discovery of new drugs, imaging, surgery, new technologies, etc.

Researchers and industrialists benefit from the unique facilities of the Vision Institute - some fifteen state-of-the-art technological platforms for eye analysis, exploration and imaging - as well as the functional evaluation platform of the Center of Clinical Investigation of CHNO of Quinze-Vingts.

Caring for patients

Researchers from the Institut de la Vision work on a daily basis with doctors from the CHNO Clinical Investigation Center in Quinze-Vingts.

This center runs more than 60 clinical studies on visual pathologies and their treatments. Current studies include age-related macular degeneration (AMD), retinopathy pigmentosa and diabetic retinal vein occlusion, artificial retina, glaucoma, and high-resolution retinal imaging.

Doctors and researchers also work closely with partner hospitals, including the A. de Rothschild Ophthalmological Foundation, AP-HP (Lariboisière and Pitié-Salpêtrière Hospitals) and the Intercommunal Hospital Center in Paris Créteil.

Statistics

  • 18 teams divided into 5 departments dedicated to academic research in
    • Biology
    • Genetics
    • Imaging tools
    • Visual Information
    • Therapeutics
    • Photonics
  • 280 researchers
  • 20 doctors
  • 12 leading-edge technological platforms
  • 50 ongoing clinical studies
  • 8 international partnering companies

 

Source: Quinze-Vingts hospital website - June 2019

NEURO SAINTE ANNE

Built in 1867, the Sainte-Anne Hospital Center has undergone many changes to become a reference center in Psychiatry and Neuroscience 

Its fields of excellence are the following:

  • Neurology
  • Neuro-vascular surgery
  • Neuro-oncology
  • Complex neuro-anesthesia and resuscitation
  • Electro-convulsivotherapy
  • Pain evaluation and treatment
  • Memory and language deficiency treatment
  • Physical medicine and neuro-orientated rehabilitation

The Neurology Department of the Sainte-Anne Hospital Center is composed of 2 units: 

  • Neurovascular Unit 
  • General Neurology Unit 

NEURO-VASCULAR UNIT (UNV) 

24-hour management of stroke patients: cerebral infarction, transient ischemic attacks, cerebral hemorrhage and meningitis. 

The UNV of Sainte Anne is one of the 4 neuro-vascular recourse units in the Île-de-France region. It has 36 beds including 10 intensive care and benefits from a unique technical platform providing 24-hour access to neuro-radiological imaging services (MRI 1.5T and 3T), interventional neuroradiology (NRI), neurosurgery and neuro-resuscitation. 

More than 1000 cardiovascular events per year are sent directly by emergency services, partner hospitals or city doctors. 

GENERAL NEUROLOGY UNIT 

Management of patients with Parkinson's disease, tremor, cervical dystonia, writer's cramp, etc. Epilepsy including initial assessment of a first seizure Multiple Sclerosis and related diseases Migraine and other headaches Peripheral nerve diseases Cerebrovascular Disorders Out of Emergency and Post-Stroke Assessment

NEURO-ONCOLOGY

Neuro-oncology is a very broad clinical and scientific discipline that concerns the diagnostic and therapeutic management of

  • Primary tumors of the central nervous system (glioma, lymphoma, meningioma ...),
  • Neurological complications of tumoral cancers (metastases of the neuroaxis and its envelopes) or not (neurological side effects of anti-neoplastic treatments, paraneoplastic syndromes ...)
  • Neuro-oncogenetic pathologies.

The neurosurgical neuro-oncology functional unit is a central operating element of the neuro Sainte-Anne hospital-university hub for the diagnosis, treatment and follow-up of all tumors of the brain, meninges and nerves.

This is made possible by a multi-disciplinary approach in connection with imaging services, neuropathology, neurology, anesthesia-resuscitation, pain, rehabilitation, psychiatry, and neurophysiology.

The unit is equipped with a state-of-the-art technical platform. Teams work closely together in Multidisciplinary Collaborative Meetings (RCP).

An example of this interaction is the ability to manage brain tumors located in high-risk areas and deemed inoperable by some teams. In particular, the expertise of the awake surgery which allows to map the brain functions during the intervention so as to remove the lesions with a maximum of security.

Neuro-oncology represents a major challenge for Neuroscience research within the Pole and Neuro Sainte-Anne's neuro-oncology department is one of the best neurosurgery services in France.

NEUROSURGICAL ANESTHESIA-RESUSCITATION SERVICE

The Anesthesia-Neurosurgical Resuscitation Department is organized into four activity centers: Anesthesia, Neurosurgical Resuscitation, Electroconvulsive Therapy Unit (ECT), Center for Assessment and Treatment of Pain (CETD)

The anesthesiologist doctor provides perioperative management (anesthesia consultation, anesthetic procedures, post-interventional monitoring) of any patient for whom an operative indication is given, whether in the context of a programmed surgery, or an indication of surgical urgency. This anesthetic activity is carried out for the benefit of patients:

  • Suffering from neurosurgical pathology, oncology surgery, epilepsy surgery or vascular surgery,
  • Or a pathology of the spine,
  • Requiring diagnostic or therapeutic management of vascular malformations by the interventional neurovascular radiology team,
  • In need of dental care or surgery of the face of patients justifying a treatment of seismotherapy

Neurosurgical resuscitation
This 10-bed unit provides continuity of care for patients managed by the surgical team or the interventional radiology team.

Electroconvulsive therapy unit
Electroconvulsive therapy (ECT) is a psychiatric treatment that consists in causing a generalized comitian crisis by means of an electric current in transcranial application.

The care of the patients by the anesthetist-intensive care physician begins as soon as the psychiatrist gives the indication with the anesthesia consultation.

This procedure is performed under short-term general anesthesia, in specific rooms that include a post-intervention monitoring room.

Center for Assessment and Treatment of Pain (CETD)
Attached to the Department of Anesthesia Neurosurgical Resuscitation, the CETD ensures:

  • Consultations (assessment, management of pain)
  • Acupuncture treatments
  • Psychological care
  • Functional rehabilitation (rehabilitation plateau, balneotherapy)
  • Emergencies
  • The service assures the care of patients admitted as part of the permanence of the local health care and the permanence of recourse (former grand guard)

 PHYSICAL MEDICINE AND NEUROLOGICAL ORIENTATION REHABILITATION (MPR)

The management of patients in the MPR service is provided by a multidisciplinary team composed of a medical practitioner MPR, nurses, caregivers, physiotherapists, occupational therapists, speech therapists, social worker, and psychologist and aims to reduce and prevent the functional, physical, psychological and social consequences of neurological deficiencies.

The MPR service has 2 units:

  • In-patient hospitalization unit
  • Out-patient hospitalization unit

In-patient hospitalization unit
Unit welcoming patients with neurological (motor, sensory, neuropsychological) sequelae neurological lesions.

Out-patient hospitalization unit
Reception of the patient in day hospitalization is proposed during a medical consultation specialized in physical medicine and rehabilitation.

Following admission consultation in MPR Day Hospital, the rehabilitation goals are set with the doctor. A weekly schedule of the proposed sessions is given to the patient with the date of the beginning and end of his / her care.

Exams performed

  • Assessment of deficiencies and sensitivo-motor disabilities in the acute phase or at a distance from a neurological condition,
  • Assessment of impairments and cognitive impairments in the acute or distant phase of a neurological condition,
  • Evaluation and treatment of spasticity:
  • Peripheral neuro-motor block
  • Botulinum toxin injection
  • Functional setting to assess patients' autonomy in activities of daily living
  • Effort rehabilitation after neurological injury
  • Disability and family specific consultations


NEUROLOGY UNIT OF MEMORY AND LANGUAGE

This unit is for patients with memory, language or cognitive impairment.

The goal is to make an accurate diagnosis and to offer multidisciplinary care adapted to the disease. Close collaboration is ensured with the assessment center psychic disorders and aging of Dr. Thierry Gallarda.
 

NEUROPHYSIOLOGY

Functional Explorations - Electroencephalography (EEG) - Electromyography (EMG) - Evoked Potentials (EP)
 

Source: website Neuro Ste Anne - June 2019